{"id":2086,"date":"2005-03-01T12:08:00","date_gmt":"2005-03-01T11:08:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2005\/leserbrief-werbung-fuer-sortis-in-der-tagespresse"},"modified":"2005-03-01T12:08:00","modified_gmt":"2005-03-01T11:08:00","slug":"leserbrief-werbung-fuer-sortis-in-der-tagespresse","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2005\/leserbrief-werbung-fuer-sortis-in-der-tagespresse","title":{"rendered":"Leserbrief: Werbung f\u00fcr Sortis\u00ae in der Tagespresse"},"content":{"rendered":"<p>Prof. Dr. M.A. aus Bremerhaven und Prof. Dr. G.K. aus Bremen schreiben zu unserem Artikel (1): >> Vieles an der Sortis\u00ae-Kampagne der Firma Pfizer mag man fragw\u00fcrdig finden. Die Emp\u00f6rung sollte im ARZNEIMITTELBRIEF aber nicht die Seriosit\u00e4t der Darstellung m\u00f6glicher praktischer Konsequenzen aus Studien beeintr\u00e4chtigen. So haben Sie es vers\u00e4umt, darauf hinzuweisen, dass nach wie [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Prof. Dr. M.A. aus Bremerhaven und Prof. Dr. G.K. aus Bremen schreiben zu unserem Artikel (1): >> Vieles an der Sortis\u00ae-Kampagne der Firma Pfizer mag man fragw\u00fcrdig finden. Die Emp\u00f6rung sollte im ARZNEIMITTELBRIEF aber nicht die Seriosit\u00e4t der Darstellung m\u00f6glicher praktischer Konsequenzen aus Studien beeintr\u00e4chtigen. So haben Sie es vers\u00e4umt, darauf hinzuweisen, dass nach wie [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[1046,451,449,2607,2606,71,455,453,498,456,65,3751,443,1561],"class_list":["post-2086","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-atorvastatin","tag-cholesterinsynthese-hemmer","tag-cse-hemmer","tag-direct-to-consumer-advertising","tag-dtca","tag-herzinfarkt","tag-hmg-coa-reduktase-hemmer","tag-hypercholesterinaemie","tag-koronare-herzkrankheit","tag-lipidsenker","tag-myokardinfarkt","tag-prove-it-studie","tag-statine","tag-werbung"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2086","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=2086"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2086\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=2086"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=2086"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=2086"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}